DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 91 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,719,070 | -56.4% | 1,036,599 | -57.6% | 0.03% | -54.0% |
| Q2 2023 | $29,163,450 | +194.8% | 2,442,500 | +230.1% | 0.06% | +186.4% |
| Q1 2023 | $9,893,800 | -86.1% | 740,000 | -77.6% | 0.02% | -87.1% |
| Q4 2022 | $71,016,000 | +16.6% | 3,300,000 | +8.6% | 0.17% | +12.6% |
| Q3 2022 | $60,891,000 | +23.8% | 3,040,000 | +10.7% | 0.15% | +33.6% |
| Q2 2022 | $49,168,000 | +2719.3% | 2,746,825 | +1462.0% | 0.11% | +3666.7% |
| Q1 2022 | $1,744,000 | -5.9% | 175,849 | +59.9% | 0.00% | 0.0% |
| Q4 2021 | $1,854,000 | -13.2% | 110,000 | +22.2% | 0.00% | -25.0% |
| Q3 2021 | $2,136,000 | – | 90,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |